| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |